Skip to main content
. Author manuscript; available in PMC: 2011 Jul 13.
Published in final edited form as: Lancet. 2009 Oct 29;374(9702):1677–1686. doi: 10.1016/S0140-6736(09)61457-4

Figure 5. Fasting glucose, glycosylated haemoglobin, and antidiabetic drug use.

Figure 5

A=fasting glucose in mmol/L. B=HbA1c (%). C=use of antidiabetic drugs (%). All participants were included irrespective of whether they developed diabetes during follow-up. Study-assigned metformin is excluded from antidiabetic drug use. Information for each data point is shown in webappendix p 7.